MedPath

Indoor rock climbing (bouldering) as a new treatment for depressio

Not Applicable
Completed
Conditions
Depression
Mental and Behavioural Disorders
Registration Number
ISRCTN17623318
Lead Sponsor
Psychiatric University Hospital Erlangen (Germany)
Brief Summary

2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26302900 results 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/31872117/ (added 18/08/2023) 2018 Results article in https://pubmed.ncbi.nlm.nih.gov/29862344/ (added 18/08/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
80
Inclusion Criteria

1. Diagnosis of depression by a psychiatrist or less than 13 points on the WHO depression scale,
2. Informed consent
3. Having free time on Thursday mornings during the intervention period
4. BMI between 18.5 and 35

Exclusion Criteria

1. Undergoing in-patient treatment during either the intervention or the waiting periods
2. Acute suicidality or psychosis
3. Medical contraindication against sport, determined by a GP or psychiatrist

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The BDI-II is used to measure the intensity of depression. Measured at baseline (t0), after 8 weeks (t1), 16 weeks (t2), and 24 weeks (t3).
Secondary Outcome Measures
NameTimeMethod
1. SCL-90-R (global intensity of psychological symptoms and distress)<br>2. FERUS (individuals' health-related resources and manageability)<br>3. d2-R (attention and concentration performance)<br>Measured at baseline (t0), after 8 weeks (t1), 16 weeks (t2), and 24 weeks (t3).
© Copyright 2025. All Rights Reserved by MedPath